BH Share Price Performance
฿0
-162.00 (-100.00%)
Price ฿0
Fair Value฿201.32
Share Pricen/a
Narrative Update • Jun 16
Bumrungrad Hospital Public Company Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
BH Community Narratives
AN
Fair Value
·Fair Value ฿201.32 7.4% undervalued intrinsic discount
New Cancer Center And Robotic Surgery Will Expand Global Capacity
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value ฿163.66 14.0% overvalued intrinsic discount
Middle East Instability And Rising Wages Will Hurt Performance
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value ฿230 18.9% undervalued intrinsic discount
Digital Health And Medical Tourism Will Transform Southeast Asia Healthcare
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Middle East Instability And Rising Wages Will Hurt Performance
Bumrungrad Hospital leans heavily on overseas patients, especially from the Middle East, which makes results vulnerable to sudden travel rules and shifting politics. At the same time, rising staffing costs and new regional rivals could squeeze profits even as the hospital expands and invests in new facilities and digital care.Read more
AN
฿163.66
14.0% overvalued intrinsic discount
Fair Value
Revenue
3.73% p.a.
Profit Margin
27.71%
Future PE
20.34x
Price in 2029
฿201.71
Digital Health And Medical Tourism Will Transform Southeast Asia Healthcare
Bumrungrad is betting that high-end cancer care, smarter digital diagnosis tools, and a growing wellness business can turn it into the go-to hospital for patients traveling across Southeast Asia. The big question is whether that growth can outpace tougher competition and the risk of relying on overseas patient flows and big new projects.Read more
AN
฿230
18.9% undervalued intrinsic discount
Fair Value
Revenue
11.14% p.a.
Profit Margin
26.44%
Future PE
24.36x
Price in 2029
฿283.47
New Cancer Center And Robotic Surgery Will Expand Global Capacity
Key Takeaways Expansion into advanced oncology, preventative medicine, and robotic surgery is strengthening high-margin service offerings and broadening the addressable market. Recovery in international patient flows and insurance partnerships is enhancing revenue diversification and supporting long-term earnings resilience.Read more
AN
฿201.32
7.4% undervalued intrinsic discount
Fair Value
Revenue
5.47% p.a.
Profit Margin
27.69%
Future PE
23.85x
Price in 2029
฿248.05
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
BH: Higher Margin Assumptions Will Eventually Fail To Justify Current Premium
Fair Value: ฿163.66 14.0% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
BH: Special Dividend And Stable Cash Flow Assumptions Will Support Upside
Fair Value: ฿230 18.9% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
BH: Dividend Windfall And Share Conversion Will Support Future Upside
Fair Value: ฿201.32 7.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
0 Risks
3 Rewards
Bumrungrad Hospital Public Company Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 14, 2026
- 9.52
- 52.40%
- 29.69%
- 0.07%
About BH
- Founded
- 1975
- Employees
- n/a
- CEO
- WebsiteView website
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Recent BH News & Updates
Narrative Update • Jun 02
BH: Special Dividend And Stable Cash Flow Assumptions Will Support Upside
Analysts have adjusted their price target for Bumrungrad Hospital from THB240 to THB230, reflecting updated views on slightly higher revenue growth and profit margins, together with a lower assumed future P/E multiple. What's in the News No recent company specific news, periodical coverage, or key developments were provided in the available sources for Bumrungrad Hospital.Narrative Update • May 02
